BNP Paribas Financial Markets Has $7.25 Million Stake in Masimo Co. (NASDAQ:MASI)

BNP Paribas Financial Markets lowered its stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 51.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 61,832 shares of the medical equipment provider's stock after selling 65,910 shares during the period. BNP Paribas Financial Markets owned approximately 0.12% of Masimo worth $7,247,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in MASI. Eminence Capital LP bought a new stake in shares of Masimo in the 3rd quarter worth approximately $90,859,000. Teachers Retirement System of The State of Kentucky boosted its stake in Masimo by 93.8% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 16,541 shares of the medical equipment provider's stock worth $1,450,000 after buying an additional 8,004 shares in the last quarter. Comerica Bank bought a new stake in Masimo in the 3rd quarter valued at $8,454,000. Sei Investments Co. raised its stake in shares of Masimo by 224.5% in the 3rd quarter. Sei Investments Co. now owns 183,940 shares of the medical equipment provider's stock valued at $16,128,000 after buying an additional 127,249 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA bought a new position in shares of Masimo during the 3rd quarter worth about $132,699,000. Institutional investors own 85.96% of the company's stock.

Insider Activity at Masimo

In other Masimo news, Director Craig B. Reynolds sold 40,000 shares of the stock in a transaction on Friday, April 26th. The stock was sold at an average price of $136.17, for a total value of $5,446,800.00. Following the transaction, the director now directly owns 7,406 shares in the company, valued at approximately $1,008,475.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 9.70% of the stock is currently owned by company insiders.

Masimo Price Performance

Masimo stock traded up $3.49 on Friday, reaching $124.10. The company's stock had a trading volume of 1,153,280 shares, compared to its average volume of 706,606. Masimo Co. has a twelve month low of $75.22 and a twelve month high of $169.58. The company has a market cap of $6.59 billion, a price-to-earnings ratio of 84.42 and a beta of 0.99. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.31 and a current ratio of 2.31. The business's fifty day moving average price is $134.76 and its 200 day moving average price is $121.79.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings data on Tuesday, May 7th. The medical equipment provider reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.06. Masimo had a net margin of 4.01% and a return on equity of 13.26%. The firm had revenue of $492.80 million for the quarter, compared to analyst estimates of $487.70 million. During the same quarter in the prior year, the firm earned $0.87 EPS. The company's revenue was down 12.8% on a year-over-year basis. Equities analysts expect that Masimo Co. will post 3.64 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on MASI. Wells Fargo & Company raised shares of Masimo from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $117.00 to $160.00 in a research report on Monday, March 25th. Piper Sandler raised their target price on Masimo from $117.00 to $126.00 and gave the stock a "neutral" rating in a research report on Wednesday, May 8th. Stifel Nicolaus upgraded Masimo from a "hold" rating to a "buy" rating and upped their price target for the company from $148.00 to $170.00 in a research report on Monday, April 15th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a report on Wednesday, May 8th. Finally, StockNews.com upgraded shares of Masimo from a "sell" rating to a "hold" rating in a research note on Friday, March 29th. Five analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $138.71.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.